Abstract:Accurate prediction of Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery, facilitating the identification of drugs that can effectively interact with specific targets and regulate their activities. While wet experiments remain the most reliable method, they are time-consuming and resource-intensive, resulting in limited data availability that poses challenges for deep learning approaches. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. To overcome this challenge, we present the SSM-DTA framework, which incorporates three simple yet highly effective strategies: (1) A multi-task training approach that combines DTA prediction with masked language modeling (MLM) using paired drug-target data. (2) A semi-supervised training method that leverages large-scale unpaired molecules and proteins to enhance drug and target representations. This approach differs from previous methods that only employed molecules or proteins in pre-training. (3) The integration of a lightweight cross-attention module to improve the interaction between drugs and targets, further enhancing prediction accuracy. Through extensive experiments on benchmark datasets such as BindingDB, DAVIS, and KIBA, we demonstrate the superior performance of our framework. Additionally, we conduct case studies on specific drug-target binding activities, virtual screening experiments, drug feature visualizations, and real-world applications, all of which showcase the significant potential of our work. In conclusion, our proposed SSM-DTA framework addresses the data limitation challenge in DTA prediction and yields promising results, paving the way for more efficient and accurate drug discovery processes. Our code is available at $\href{<a class="link-external link-https" href="https://github.com/QizhiPei/SSM-DTA" rel="external noopener nofollow">this https URL</a>}{Github}$.

MISATO - Machine Learning Dataset for Structure-Based Drug Discovery

MISATO: machine learning dataset of protein-ligand complexes for structure-based drug discovery

Modern Semiempirical Electronic Structure Methods and Machine Learning Potentials for Drug Discovery: Conformers, Tautomers, and Protonation States

Binding Affinity Prediction with 3D Machine Learning: Training Data and Challenging External Testing

AMPL: A Data-Driven Modeling Pipeline for Drug Discovery

SPICE, A Dataset of Drug-like Molecules and Peptides for Training Machine Learning Potentials

Structure prediction of protein-ligand complexes from sequence information with Umol

MolData, a molecular benchmark for disease and target based machine learning

Artificial intelligence in drug discovery: recent advances and future perspectives

SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction

Structure-based drug discovery with deep learning

Machine Learning for Sequence and Structure-Based Protein–Ligand Interaction Prediction

SIU: A Million-Scale Structural Small Molecule-Protein Interaction Dataset for Unbiased Bioactivity Prediction

Drug Discovery SMILES-to-Pharmacokinetics Diffusion Models with Deep Molecular Understanding

Development and evaluation of a deep learning model for protein-ligand binding affinity prediction

PLAS-20k: Extended Dataset of Protein-Ligand Affinities from MD Simulations for Machine Learning Applications

State of the Art and Outlook of Data Science and Machine Learning in Organic Chemistry

Machine Learning of Molecular Electronic Properties in Chemical Compound Space

A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios

Synergizing Chemical Structures and Bioassay Descriptions for Enhanced Molecular Property Prediction in Drug Discovery

Unraveling Molecular Structure: A Multimodal Spectroscopic Dataset for Chemistry